Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder Agitation and an Altered Mental Status in the Emergency Department: Differential Diagnosis, Evaluation, and Treatment PDF $40.00
$40.00
× Placeholder Major Depressive Disorder Induced by Chronic Ketamine Abuse: A Case Report PDF $40.00
$40.00
× Placeholder Personality Modulates the Efficacy of Treatment in Patients With Major Depressive Disorder PDF $40.00
$40.00
× Placeholder Duloxetine Treatment for Role Functioning Improvement in Generalized Anxiety Disorder: Three Independent Studies PDF $40.00
$40.00
× Placeholder d-Cycloserine Facilitation of Exposure Therapy Improves Weight Regain in Patients With Anorexia Nervosa: A Pilot Randomized Controlled Trial PDF $40.00
$40.00
× Placeholder Efficacy and Safety of Aripiprazole and Haloperidol Versus Placebo in Patients With Schizophrenia and Schizoaffective Disorder PDF $40.00
$40.00
× Placeholder Risperidone in Acutely Exacerbated Schizophrenia: Dosing Strategies and Plasma Levels PDF $40.00
$40.00
× Placeholder Poor Long-Term Prognosis in Mixed Bipolar Patients: 10-Year Outcomes in the Vitoria Prospective Naturalistic Study in Spain PDF $40.00
$40.00
× Placeholder A Case of Elexacaftor/Tezacaftor/Ivacaftor–Induced Depressive Symptoms and Suicidal Thoughts PDF $40.00
$40.00
× Placeholder Relationship Between Costs and Symptoms in Schizophrenia Patients Treated With Antipsychotic Medication: A Review PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $400.00
Total $400.00
Proceed to checkout

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure shows a syringe and vials with title on aripiprazole monohydrate LAI use in schizophrenia and a red READ NOW button.

Subscribe to read
more articles

Subscribe